The Desmond Tutu
HIV Foundation

Pairing rigorous research with community-driven development, the DTHF is making a substantial contribution to service delivery and public health policy relating to HIV, tuberculosis and related infections in South Africa.

About Us Our People

HIV weekly news update in partnership with MedicalBrief

  • MEDICALBRIEF Issue No 0142 - HIV News 16 Feb 2017

    Trial identifies substantial primary drug resistance but with no impact on treatment outcomes

    A study of the prevalence of transmitted drug resistance in participants in the ANRS 12249 trial of treatment as prevention has found that 8.4% of participants in the trial had HIV with primary resistance mutations against the virus. There was, surprisingly, no association between having drug resistance mutations and virologic failure.
  • MEDICALBRIEF Issue No 0142 - HIV News 16 Feb 2017

    New integrase inhibitor bictegravir matches dolutegravir for first-line treatment

    Bictegravir, an investigational integrase inhibitor from Gilead Sciences, was highly potent, well tolerated and worked as well as dolutegravir in a phase 2 clinical trial, according to study results presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
  • MEDICALBRIEF Issue No 0142 - HIV News 16 Feb 2017

    Dual antiretroviral regimen maintains durable HIV suppression after switch

    People who switched from standard antiretroviral therapy to a two-drug regimen of dolutegravir plus rilpivirine were able to maintain an undetectable viral load for 48 weeks in a pair of late-stage clinical trials.
  • MEDICALBRIEF Issue No 0142 - HIV News 16 Feb 2017

    Living longer with HIV associated with depression

    Longer time living with diagnosed HIV infection is strongly associated with depression, anxiety and poor quality of life, according to UK research.
  • MEDICALBRIEF Issue No 0142 - HIV News 16 Feb 2017

    Linkage to care following HIV diagnosis the biggest weakness

    A study carried out through the Africa Health Research Institute in KwaZulu-Natal, found that less than half of the population with HIV in the district had linked to care within eight years, despite the fact that 82% were aware of their HIV infection.
View All

Our Research


DTHF receives the Ubuntu Social Responsibility Award 2017

DTHF received the UBUNTU Award for Social Responsibility at a gala event in Cape Town on 17th February.   The evening …
Read More

The Zimele Project: Launch

This January, there was a buzz of excitement at Philippi Village as 120 new staff members arrived ready to make …
Read More

HIV Vaccine Trial to be launched in South Africa

“We’ve never treated our way out of an epidemic. There’s no doubt we have to have primary prevention alongside treatment …
Read More

9 Steps to an HIV Prevention Revolution in Resource-Limited Settings

It’s 3 decades into the war with HIV/AIDS and so far 78 million have been infected and 39 million people …
Read More

Our Projects

Sensitivity Training

Key Populations Integrated Sensitivity Training Programme The Key Population Research Department leads the development of a health care worker sensitization …
Read More

The Tutu Tester

The Tutu Tester mobile unit provides a free comprehensive health service to under serviced communities. It is in the field …
Read More

Adult HIV Educational Programme

The manual for this distance learning course for doctors and nurses was updated in July 2015 to reflect the latest policies …
Read More


Youth Centre
Youth Centre

The DTHF Youth Centre

The DTHF Youth Centre complex in Masiphumelele was built in response to requests from the community for a safe, recreational space for young people. DTHF surveys record a high prevalence of HIV infection among youth in the community.

Visit the Youth Centre